South Korea
· Delayed Price · Currency is KRW Anterogen.Co.,Ltd. Company Description
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally.
The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn’s fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension.
It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as stem cell media program set, a cosmetic raw material.
In addition, the company offers stem cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Seong-Gu Lee |
Contact Details
Address: 345-30 Gasan-dong Seoul, 08589 South Korea | |
| Phone | 82 2 2104 0391 |
| Website | anterogen.com |
Stock Details
| Ticker Symbol | 065660 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Seong-Gu Lee | Chief Executive Officer |